科研之友
微信
新浪微博
Facebook
分享链接
摘要
Overactivation of both Polo-like kinase-1 (Plk1) and Aurora-A is linked to cancer development, and small-molecule inhibitors that target these kinases are currently tested as anticancer drugs. Here, we discuss recent advances in the understanding of the functional crosstalk between Plk1 and Aurora-A before and during mitosis. Several recent findings have led to a better appreciation of how the activities of these distinct mitotic kinases are intertwined. Such insight is important for the expected utility of small-molecule inhibitors targeting Plk-1 or Aurora-A, and it might help us to improve their application. [Cancer Res 2009;69(11):4555-8]
- 出版日期2009-6-1
